CCL19 Protéine
-
- Antigène Voir toutes CCL19 Protéines
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
- Type de proteíne
- Recombinant
- Activité biologique
- Active
-
Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Séquence
- GTNDAEDCCL SVTQKPIPGY IVRNFHYLLI KDGCRVPAVV FTTLRGRQLC APPDQPWVER IIQRLQRTSA KMKRRSS
- Attributs du produit
-
Purified recombinant Human MIP3 beta protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoattract human T cells using a concentration of 10.0-50.0 ng/mL. - Pureté
- > 98 % pure
- niveau d'endotoxine
- < 0.1 ng per µg (1 EU/µg).
- Top Product
- Discover our top product CCL19 Protéine
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute in water to a concentration of 0.1-1.0 mg/mL
- Buffer
- Supplied lyophilized with no additives.
- Agent conservateur
- Without preservative
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- RT/-20 °C
-
- Antigène
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
- Autre désignation
- MIP3 beta (CCL19 Produits)
- Synonymes
- CKb11 Protein, ELC Protein, MIP-3b Protein, MIP3B Protein, SCYA19 Protein, CCL19 Protein, Scya19 Protein, exodus-3 Protein, C-C motif chemokine ligand 19 Protein, chemokine (C-C motif) ligand 19 Protein, CCL19 Protein, ccl19 Protein, Ccl19 Protein
- Sujet
-
MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on Mouse cells.
Alternative Names: CCL19 protein, MIP beta 3, MIP3 beta, MIP-3 beta protein, MIP beta 3 protein, Exodus-3 protein, MIP beta-3 protein, ELC protein, MIP beta-3, Macrophage Inflammatory Protein-3 beta protein - Poids moléculaire
- 8.8 kDa
- Pathways
- Positive Regulation of Immune Effector Process
-